FDA approves daraxonrasib, the first targeted pill for advanced pancreatic cancer, offering patients longer survival and fewer side effects.
Browsing: pancreatic cancer
Indian American physician-scientist Dr. Vinod Balachandran says mRNA vaccines may reduce risk of disease coming back after surgery.
Indian American physician-scientist led trial found half of the patients remained cancer-free 18 months after receiving the jabs
Pancreatic cancer has the highest mortality rate of all cancers.